Phase I Research at Providence Cancer Center

April 25, 2016

More than 30 phase I clinical trials are currently open at Providence Cancer Center

Phase I studies are the foundation for advancing cancer treatment with novel agents and combinations of therapies. Providence Cancer Center is proud to offer our patients highly innovative treatment options, many of which include clinical trials.

Our team of investigators works closely with other leading scientists around the country to develop and initiate trials of novel agents to treat cancer. Through our own investigator-sponsored trials, as well as partnerships with industry sponsors and collaborations with other early-phase institutions around the country, we are often able to offer first-in-human trials of the newest cancer therapies to our patients.

An exceptional team

The phase I research program at the Earle A. Chiles Research Institute at Providence Cancer Center is made up of oncologist leaders, phase-I-dedicated nurses, data coordinators and lab assistants. Every person on this exceptional team is passionate about offering breakthrough therapies and the best possible treatment to our patients.

Current phase I trials

Our panel of trials focuses largely on immunotherapies, but also includes targeted therapies and other innovative agents. We currently offer more than 30 phase I clinical trials in these areas:

New studies are added frequently. For a complete list of all current studies at Providence Cancer Center, including phase I, II and III clinical trials, please visit our website. For more information, call 503-215-2614.